RSS-Feed abonnieren

DOI: 10.1055/s-0045-1810063
Herbal Medicines: The Double-Edged Sword for Brain—A Narrative Update

Abstract
Phytochemicals or herbal medicines (HMs) with neuroprotective and nootropic properties are being increasingly utilized in various neurological conditions owing to their antioxidative, anti-inflammatory, and antiapoptotic properties, as well as their role in immune regulation, hormonal regulation, and modulation of neurotransmitters and ion channels. While HMs are often regarded as safe, they are not without risks. The aim of this review was to know the various neurological and non-neurological side effects of long-term consumption of neuroprotective and nootropic phytochemicals. An electronic search was conducted using the following databases from January 2000 to December 2023: PubMed, PubMed Central, Embase, Scopus, and Science Citation Index (Web of Science). Only studies published in the English language were considered. The search used key terms such as “Herbs,” “Phytochemicals,” “India,” “Asia,” “Neuroprotection,” “Neurological diseases,” and “Complications.” The sources included research articles, systematic reviews and meta-analyses, narrative reviews, and editorials. Letters to the editor, commentaries, abstracts only, and unpublished data were excluded. While HMs are increasingly being used therapeutically for various neurological and non-neurological conditions, they also carry the risk of adverse effects due to contamination, adulteration, direct effects of metabolites, herb–drug interactions, interindividual susceptibility, and other factors. In addition, widespread availability, over-the-counter sale, and unsupervised dosing are the key reasons for their unregulated prolonged use. As such, correct identification of HMs and consequent assessment of their toxicological profile are deemed extremely crucial. Neurotoxicity testing for HMs is challenging considering the limitations of traditional methods (morphological, microscopic, and chemical); nevertheless, in the recent years, several novel procedures have been developed. Large studies are warranted to establish the safety profile of consuming HMs either alone or in combination in humans.
Publikationsverlauf
Artikel online veröffentlicht:
01. August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Pan SY, Litscher G, Gao SH. et al. Historical perspective of traditional indigenous medical practices: the current renaissance and conservation of herbal resources. Evid Based Complement Alternat Med 2014; 2014: 525340
- 2 Kurhekar JV. Ancient and modern practices in phytomedicine. In: Egbuna C, Prakash Mishra A, Goyal MG. eds. Preparation of Phytopharmaceuticals for the Management of Disorders. Cambridge, MA: Academic Press; 2021: 55-75
- 3 Pan SY, Pan S, Yu ZL. et al. New perspectives on innovative drug discovery: an overview. J Pharm Sci 2010; 13 (03) 450-471
- 4 Halder S, Anand U, Nandy S. et al. Herbal drugs and natural bioactive products as potential therapeutics: a review on pro-cognitives and brain boosters perspectives. Saudi Pharm J 2021; 29 (08) 879-907
- 5 Fan F, Lei M. Mechanisms underlying curcumin-induced neuroprotection in cerebral ischemia. Front Pharmacol 2022; 13: 893118
- 6 Feng Z, Sun Q, Chen W, Bai Y, Hu D, Xie X. The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review. Mol Med 2019; 25 (01) 57
- 7 Xue R, Gao S, Zhang Y. et al. A meta-analysis of resveratrol protects against cerebral ischemia/reperfusion injury: evidence from rats studies and insight into molecular mechanisms. Front Pharmacol 2022; 13: 988836
- 8 Keshavarzi Z, Shakeri F, Barreto GE, Bibak B, Sathyapalan T, Sahebkar A. Medicinal plants in traumatic brain injury: neuroprotective mechanisms revisited. Biofactors 2019; 45 (04) 517-535
- 9 Lee B, Leem J, Kim H, Jo HG, Kwon CY. Herbal medicine for traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials and limitations. Front Neurol 2020; 11: 772
- 10 Wakade C, King MD, Laird MD, Alleyne Jr CH, Dhandapani KM. Curcumin attenuates vascular inflammation and cerebral vasospasm after subarachnoid hemorrhage in mice. Antioxid Redox Signal 2009; 11 (01) 35-45
- 11 Tan J, Song R, Luo S. et al. Efficacy of resveratrol in experimental subarachnoid hemorrhage animal models: a stratified meta-analysis. Front Pharmacol 2022; 13: 905208
- 12 Amro MS, Teoh SL, Norzana AG, Srijit D. The potential role of herbal products in the treatment of Parkinson's disease. Clin Ter 2018; 169 (01) e23-e33
- 13 Yin R, Xue J, Tan Y. et al. The positive role and mechanism of herbal medicine in Parkinson's disease. Oxid Med Cell Longev 2021; 2021: 9923331
- 14 Lum PT, Sekar M, Gan SH, Bonam SR, Shaikh MF. Protective effect of natural products against Huntington's disease: an overview of scientific evidence and understanding their mechanism of action. ACS Chem Neurosci 2021; 12 (03) 391-418
- 15 Vishwas S, Gulati M, Kapoor B. et al. Expanding the arsenal against Huntington's disease-herbal drugs and their nanoformulations. Curr Neuropharmacol 2021; 19 (07) 957-989
- 16 Gregory J, Vengalasetti YV, Bredesen DE, Rao RV. Neuroprotective herbs for the management of Alzheimer's disease. Biomolecules 2021; 11 (04) 543
- 17 Mehla J, Gupta P, Pahuja M, Diwan D, Diksha D. Indian medicinal herbs and formulations for Alzheimer's disease, from traditional knowledge to scientific assessment. Brain Sci 2020; 10 (12) 964
- 18 Mojaverrostami S, Bojnordi MN, Ghasemi-Kasman M, Ebrahimzadeh MA, Hamidabadi HG. A review of herbal therapy in multiple sclerosis. Adv Pharm Bull 2018; 8 (04) 575-590
- 19 Costantini E, Masciarelli E, Casorri L, Di Luigi M, Reale M. Medicinal herbs and multiple sclerosis: overview on the hard balance between new therapeutic strategy and occupational health risk. Front Cell Neurosci 2022; 16: 985943
- 20 Trogrlić I, Trogrlić D, Trogrlić D, Trogrlić AK. Treatment of glioblastoma with herbal medicines. World J Surg Oncol 2018; 16 (01) 28
- 21 Mian SY, Nambiar A, Kaliaperumal C. Phytotherapy for the treatment of glioblastoma: a review. Front Surg 2022; 9: 844993
- 22 Aghdash SN. Herbal medicine in the treatment of epilepsy. Curr Drug Targets 2021; 22 (03) 356-367
- 23 Liu W, Ge T, Pan Z, Leng Y, Lv J, Li B. The effects of herbal medicine on epilepsy. Oncotarget 2017; 8 (29) 48385-48397
- 24 Levin M. Herbal treatment of headache. Headache 2012; 52 (2, Suppl 2): 76-80
- 25 Lyu S, Zhang CS, Guo X. et al. Efficacy and safety of oral Chinese herbal medicine for migraine: a systematic review and meta-analyses using robust variance estimation model. Front Neurol 2022; 13: 889336
- 26 Priya CS, Venkataswamy M, Harshini G, Pravalika P, Mandadi S, Bandla J. Medicinal plants used for the treatment of bacterial meningitis. Res J Pharm Dos Forms Technol 2019; 11: 239-244
- 27 Ushir K, Rishipathak D, Bhosale P, Raut M. Ayurvedic remedies of bacterial meningitis. Int J Pharm Sci 2021; 1: 12-20
- 28 Zhang W, Yan Y, Wu Y. et al. Medicinal herbs for the treatment of anxiety: a systematic review and network meta-analysis. Pharmacol Res 2022; 179: 106204
- 29 Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal medicine for anxiety, depression and insomnia. Curr Neuropharmacol 2015; 13 (04) 481-493
- 30 Kenda M, Kočevar Glavač N, Nagy M, Sollner Dolenc M. Medicinal plants used for anxiety, depression, or stress treatment: an update. Molecules 2022; 27 (18) 6021
- 31 Parvez MK. Natural or plant products for the treatment of neurological disorders: current knowledge. Curr Drug Metab 2018; 19 (05) 424-428
- 32 Luthra R, Roy A. Role of medicinal plants against neurodegenerative diseases. Curr Pharm Biotechnol 2022; 23 (01) 123-139
- 33 Karim N, Abdelhalim H, Gavande N, Khan I, Khan H. Natural products as an emerging therapeutic alternative in the treatment of neurological disorders. Evid Based Complement Alternat Med 2018; 2018: 3056847
- 34 Iriti M, Vitalini S, Fico G, Faoro F. Neuroprotective herbs and foods from different traditional medicines and diets. Molecules 2010; 15 (05) 3517-3555
- 35 Safdari MR, Shakeri F, Mohammadi A. et al. Role of herbal medicines in the management of brain injury. Adv Exp Med Biol 2021; 1328: 287-305
- 36 Ghosh S, Singha PS, Ghosh D. Neuroprotective compounds from three common medicinal plants of West Bengal, India: a mini review. Explor Neurosci 2023; 2: 307-317
- 37 Wongkrajang Y, Kitphati W, Kongsaktrakoon B, Temsiririrkkul R. Potential risks and hazards from herbal uses. JAASP 2014; 3: 280-289
- 38 Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front Pharmacol 2014; 4: 177
- 39 Başaran N, Paslı D, Başaran AA. Unpredictable adverse effects of herbal products. Food Chem Toxicol 2022; 159: 112762
- 40 Ernst E. Serious psychiatric and neurological adverse effects of herbal medicines: a systematic review. Acta Psychiatr Scand 2003; 108 (02) 83-91
- 41 Kahraman C, Arituluk ZC, Cankaya IIT. The clinical importance of herb-drug interactions and toxicological risks of plants and herbal products. In: Medical Toxicology. London: IntechOpen; 2021
- 42 Wilson V, Maulik SK. Herb-drug interactions in neurological disorders: a critical appraisal. Curr Drug Metab 2018; 19 (05) 443-453
- 43 Opuni KFM, Kretchy JP, Agyabeng K. et al. Contamination of herbal medicinal products in low-and-middle-income countries: a systematic review. Heliyon 2023; 9 (09) e19370
- 44 Fatima N, Nayeem N. Toxic effects as a result of herbal medicine intake. In: Toxicology: New Aspects to This Scientific Conundrum. London: IntechOpen; 2016
- 45 Jităreanu A, Trifan A, Vieriu M, Caba I-C, Mârțu I, Agoroaei L. Current trends in toxicity assessment of herbal medicines: a narrative review. Processes (Basel) 2023; 11: 83
- 46 Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviews. Clin Med (Lond) 2013; 13 (01) 7-12
- 47 Bhalla A, Pannu AK. Are ayurvedic medications store house of heavy metals?. Toxicol Res (Camb) 2022; 11 (01) 179-183
- 48 Bisht VK, Uniyal RC, Sharma SM. Assessment of heavy metal content in herbal raw materials traded in India. S Afr J Bot 2022; 148: 154-161
- 49 Williamson EM. Herbal neurotoxicity: an introduction to its occurrence and causes. In: Pelkonen O, Duez P, Vuorela P, Vuorela H. eds. Toxicology of Herbal Products. Cham: Springer; 2017
- 50 Bal-Price AK, Hogberg HT, Buzanska L, Lenas P, van Vliet E, Hartung T. In vitro developmental neurotoxicity (DNT) testing: relevant models and endpoints. Neurotoxicology 2010; 31 (05) 545-554
- 51 Sahu R, Gupta PK, Mishra A, Kumar A. Ayurveda and in silico approach: a challenging proficient confluence for better development of effective traditional medicine spotlighting network pharmacology. Chin J Integr Med 2023; 29 (05) 470-480
- 52 Durán-Iturbide NA, Díaz-Eufracio BI, Medina-Franco JL. In silico ADME/Tox profiling of natural products: a focus on BIOFACQUIM. ACS Omega 2020; 5 (26) 16076-16084
- 53 Neergheen-Bhujun VS. Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. BioMed Res Int 2013; 2013: 804086
- 54 Zhang J, Onakpoya IJ, Posadzki P, Eddouks M. The safety of herbal medicine: from prejudice to evidence. Evid Based Complement Alternat Med 2015; 2015: 316706
- 55 Wang H, Chen Y, Wang L, Liu Q, Yang S, Wang C. Advancing herbal medicine: enhancing product quality and safety through robust quality control practices. Front Pharmacol 2023; 14: 1265178